Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Wander

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Onkologie|December 1, 1988
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding studyG A Nagel, J H Beyer, W Holtkamp, et al.
Seminars in Oncology|April 1, 1992
Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer--preliminary results of a randomized trialB Steinke, E Günther, W D Hirschmann, et al.
British Journal of Cancer|August 1, 1996
A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitorI Smith, A Jones, M Spielmann, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Onkologie|December 1, 1988
High-dose epirubicin + cyclophosphamide (HD-EC) in metastatic breast cancer: a dose-finding studyG A Nagel, J H Beyer, W Holtkamp, et al.
Seminars in Oncology|April 1, 1992
Fluorouracil versus folinic acid/fluorouracil in advanced colorectal cancer--preliminary results of a randomized trialB Steinke, E Günther, W D Hirschmann, et al.
British Journal of Cancer|August 1, 1996
A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitorI Smith, A Jones, M Spielmann, et al.
Pageof 4